-
1
-
-
0017072068
-
Characterization of the metabolites of methyl n-butyl ketone, methyl iso-butyl ketone, and methyl ethyl ketone in guinea pig serum and their clearance
-
DiVincenzo GD et al. (1976) Characterization of the metabolites of methyl n-butyl ketone, methyl iso-butyl ketone, and methyl ethyl ketone in guinea pig serum and their clearance. Toxicol Appl Pharmacol 36: 511-522
-
(1976)
Toxicol Appl Pharmacol
, vol.36
, pp. 511-522
-
-
DiVincenzo, G.D.1
-
2
-
-
0017877268
-
Biotransformation of n-hexane and methyl n-butyl ketone in guinea-pigs and mice
-
Couri D et al. (1978) Biotransformation of n-hexane and methyl n-butyl ketone in guinea-pigs and mice. Am Ind Hyg Assoc J 39: 295-300
-
(1978)
Am ind Hyg Assoc J
, vol.39
, pp. 295-300
-
-
Couri, D.1
-
3
-
-
0001594154
-
An occurence of polyneuritis by n-hexane in the polyethylene laminating plants
-
Yamada S (1964) An occurence of polyneuritis by n-hexane in the polyethylene laminating plants. Jpn J Ind Health 6: 192-197
-
(1964)
Jpn J ind Health
, vol.6
, pp. 192-197
-
-
Yamada, S.1
-
4
-
-
85007921969
-
Intoxication polyneuritis in the workers exposed to n-hexane
-
Yamada S (1967) Intoxication polyneuritis in the workers exposed to n-hexane. Jpn J Ind Health 9: 651-659
-
(1967)
Jpn J ind Health
, vol.9
, pp. 651-659
-
-
Yamada, S.1
-
5
-
-
84996364546
-
A health survey on vinyl sandal manufacturers with high incidence of n-hexane intoxication
-
Inoue T et al. (1970) A health survey on vinyl sandal manufacturers with high incidence of n-hexane intoxication. Jpn J Ind Health 12: 73-84
-
(1970)
Jpn J ind Health
, vol.12
, pp. 73-84
-
-
Inoue, T.1
-
6
-
-
0016154569
-
Toxic polyneuropathy produced by methyl n-butyl ketone
-
Mendell JR et al. (1974) Toxic polyneuropathy produced by methyl n-butyl ketone. Science 35: 787-789
-
(1974)
Science
, vol.35
, pp. 787-789
-
-
Mendell, J.R.1
-
7
-
-
0018843926
-
The relative neurotoxicity of methyl-n-butyl ketone, n-hexane and their metabolites
-
Krasavage WJ et al. (1980) The relative neurotoxicity of methyl-n-butyl ketone, n-hexane and their metabolites. Toxicol Appl Pharmacol 52: 433-441
-
(1980)
Toxicol Appl Pharmacol
, vol.52
, pp. 433-441
-
-
Krasavage, W.J.1
-
8
-
-
0016820609
-
Experimental neuropathy produced by 2,5-hexanedione - A major metabolite of the neurotoxic industrial solvent methyl n-butyl ketone
-
Spencer PS, Schaumburg HH (1975) Experimental neuropathy produced by 2,5-hexanedione - a major metabolite of the neurotoxic industrial solvent methyl n-butyl ketone. J Neurol Neurosurg Psychiatry 38: 771-775
-
(1975)
J Neurol Neurosurg Psychiatry
, vol.38
, pp. 771-775
-
-
Spencer, P.S.1
Schaumburg, H.H.2
-
9
-
-
0021189844
-
Further observations on in vitro and in vivo effects of 2,5-hexanedione on glyceraldehyde-3-phosphate dehydrogenase
-
Sabri MI (1984) Further observations on in vitro and in vivo effects of 2,5-hexanedione on glyceraldehyde-3-phosphate dehydrogenase. Arch Toxicol 55: 191-194
-
(1984)
Arch Toxicol
, vol.55
, pp. 191-194
-
-
Sabri, M.I.1
-
10
-
-
0023125960
-
Uncoupling of cerebral glucose supply and utilization after hexane-2,5-dione intoxication in the rat
-
[published erratum appears in J Neurochem 49:995 (1987)].
-
Planas AM, Cunningham VJ (1987) Uncoupling of cerebral glucose supply and utilization after hexane-2,5-dione intoxication in the rat [published erratum appears in J Neurochem 49:995 (1987)]. J Neurochem 48: 816-823
-
(1987)
J Neurochem
, vol.48
, pp. 816-823
-
-
Planas, A.M.1
Cunningham, V.J.2
-
11
-
-
0021258573
-
In vitro evidence that covalent crosslinking of neurofilaments occurs in gamma-diketone neuropathy
-
Graham DG et al. (1984) In vitro evidence that covalent crosslinking of neurofilaments occurs in gamma-diketone neuropathy. Proc Nat Acad Sci USA 81: 4979-4982
-
(1984)
Proc Nat Acad Sci USA
, vol.81
, pp. 4979-4982
-
-
Graham, D.G.1
-
12
-
-
0021821585
-
Alterations in rat axonal cytoskeletal proteins induced by in vitro and in vivo 2,5-hexanedione exposure
-
DeCaprio AP, O'Neill EA (1985) Alterations in rat axonal cytoskeletal proteins induced by in vitro and in vivo 2,5-hexanedione exposure. Toxicol Appl Pharmacol 78 :235-247
-
(1985)
Toxicol Appl Pharmacol
, vol.78
, pp. 235-247
-
-
DeCaprio, A.P.1
O'Neill, E.A.2
-
13
-
-
0023873976
-
Comparative neurotoxicity and pyrrole-forming potential of 2,5-hexanedione and perdeuterio-2,5-hexanedione in the rat
-
DeCaprio AP et al. (1988) Comparative neurotoxicity and pyrrole-forming potential of 2,5-hexanedione and perdeuterio-2,5-hexanedione in the rat. Toxicol Appl Pharmacol 92: 75-85
-
(1988)
Toxicol Appl Pharmacol
, vol.92
, pp. 75-85
-
-
DeCaprio, A.P.1
-
14
-
-
0023887103
-
Pyrrole oxidation and protein cross-linking as necessary steps in the development of gamma-diketone neuropathy
-
Genter St. Clair MB et al. (1988) Pyrrole oxidation and protein cross-linking as necessary steps in the development of gamma-diketone neuropathy. Chem Res Toxicol 1: 179-185
-
(1988)
Chem Res Toxicol
, vol.1
, pp. 179-185
-
-
Genter St Clair, M.B.1
-
15
-
-
0026648674
-
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
-
Gavrieli Y et al. (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501
-
(1992)
J Cell Biol
, vol.119
, pp. 493-501
-
-
Gavrieli, Y.1
-
16
-
-
0026740599
-
2,5-Hexanedione is a potent gliatoxin in in-vitro cell cultures of the nervous system
-
Boegner F et al. (1992) 2,5-Hexanedione is a potent gliatoxin in in-vitro cell cultures of the nervous system. Neurotoxicology 13: 151-154
-
(1992)
Neurotoxicology
, vol.13
, pp. 151-154
-
-
Boegner, F.1
-
17
-
-
0002204915
-
Definition and incidence of apoptosis: An historical perspective
-
Tomei LD, Cope FO (eds) Cold Spring Harbor Laboratory Press, New York
-
Kerr JFR, Harmon BV (1991) Definition and incidence of apoptosis: An historical perspective. In: Tomei LD, Cope FO (eds) Apoptosis: The molecular basis of cell death. Cold Spring Harbor Laboratory Press, New York, pp 5-29
-
(1991)
Apoptosis: the Molecular Basis of Cell Death
, pp. 5-29
-
-
Kerr, J.F.R.1
Harmon, B.V.2
|